The European Parliament Panel for the Future of Science and Technology (STOA) is organising a workshop in cooperation with the BioMed Alliance, the European Society of Cardiology (ESC), the European Haematology Association (EHA) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). The workshop will focus on the new the In Vitro Diagnostics Regulation (IVDR) and the need for more evidence-based EU health related policies.
The COVID-19 pandemic has highlighted the importance of science in public life and the need for policy decisions and regulatory systems to be guided by scientific and clinical evidence. Scientific input is crucial to ensure that health policy initiatives can lead to better public health and enhance resources for patients. The goal of the workshop is to inform MEPs about the implementation of the new IVDR and its consequences for the health system. Discussions will also focus on the need for early engagement with medical experts to help to ensure that EU health-related legislation matches the situation in practice to ensure effective, evidence-based EU health initiatives that are targeted towards the unmet needs of patients and public health systems.
The meeting will be chaired by MEP Alexandra Geese, member of the STOA panel, and gather prominent experts on the questions related to medical devices and in-vitro diagnostics, health data and evidence-based health policies.
Please register your participation using the registration link attached and we very much look forward to welcoming you!
22 Apr 2021 @ 02:00 pm
22 Apr 2021 @ 04:00 pm
Duration: 2 hours
English en